BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 1999
View Archived Issues
Chinese authorities approve Matritech's bladder cancer test
Read More
Patient enrollment in Vion's Promycin trial increases during Q2 1999
Read More
Emisphere Technologies foresees initiation of phase III testing for oral heparin
Read More
Incara subsidiary licenses rights to liver progenitor cell technology
Read More
5-HT4 receptor ligands studied extensively at Roche Bioscience
Read More
Evacet/Taxol combination enters advanced breast cancer trials
Read More
Long-term tolterodine reduces incontinence, is well tolerated
Read More
Herceptin approved in Canada for breast cancer therapy
Read More
Innogenetics acquires TRAx product line from Avant Immunotherapeutics
Read More
Long-term continuation rate good for Alza's overactive bladder therapy
Read More
Cerebrus researches GABA-A ligands for treating CNS disorders
Read More
AMD-3329 is a more potent derivative of the CXCR4 antagonist AMD-3100
Read More
Molecular Biosystems successfully completes phase II studies of Optison
Read More
NuOncology Labs awarded second U.S. patent
Read More
NaPro BioTherapeutics focuses on new anticancer programs
Read More
Tularik discovers new PPAR-gamma modulators for treating diabetes
Read More
Cytotoxic macrolide compounds HA-1 and TH-2 obtained from marine sources
Read More
Oral bioavailability of thrombin inhibitor S-31922 shows reduced variability in the presence of food
Read More
Servier researchers present S-31214, a potent and selective thrombin inhibitor, at ACS
Read More
LeukoSite, Kyowa Hakko collaborate on the study of chemokine receptor antagonists
Read More
Still in the news: vasopeptidase inhibitor omapatrilat a protagonist in Barcelona
Read More
Preclinical studies of abetafen show potential for treatment of prostate disease
Read More
News from ACS: hepatitis C viral protease inhibitor BILN-303-SE
Read More
LB-42908 inhibits protein farnesyltransferase in vitro, in vivo
Read More
Final results of REACH-1 now in, support efficacy of bosentan in CHF
Read More
U of M research team studies new compounds for imaging prostate cancer
Read More
